Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease

Pulmonary hypertension (PH) with developmental lung disease is a life-threatening disease and accounts for 10%–12% of pediatric PH patients. Administration of specific pulmonary vasodilators to pediatric PH patients has brought about improvement of their long-term prognosis. Intravenous epoprostenol...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Frontiers in Pediatrics
المؤلفون الرئيسيون:	Yoshie Fukasawa, Hidenori Yamamoto, Miharu Ito, Akiko Saito, Kiyotaka Go, Yoshihito Morimoto, Kazushi Yasuda, Yoshiaki Sato, Masahiro Hayakawa, Taichi Kato
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2023-03-01
الموضوعات:	pulmonary hypertension developmental lung disease epoprostenol congenital diaphragmatic hernia alveolar capillary dysplasia with misalignment of pulmonary veins bronchopulmonary dysplasia
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fped.2023.1116434/full